IP Library Granted Patent US 8,734,861
Granted Patent B2
US 8,734,861 · App. 13/355,539 · Granted May 27, 2014

Bioactive botanical cosmetic compositions and processes for their production

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,734,861
App. No.
13/355,539
Granted
May 27, 2014
Kind
B2
Abstract

The present invention is directed to bioactive botanical cosmetic compositions derived from membrane and cell serum fractions of plant cell juice. The present invention also relates to the methods for preparing these bioactive botanical cosmetic compositions and the uses of these compositions in various cosmetic formulations and as topical skin cosmetic applications.

Claims (71)

1. A bioactive botanical cosmetic composition comprising:

a cosmetically effective amount of a cell serum fraction derived from cell juice extracted from a fresh plant biomass, said cell serum fraction having antioxidant activity, cell growth stimulation activity, and/or both antioxidant and cell growth stimulation activities, wherein said fresh plant biomass is plant tissue of plants selected from the group consisting of Asteraceae, Fabaceae, Lamiaceae, and Poaceae; and

a stabilizing agent, wherein said cell growth stimulation activity is due to stimulation of proliferation of at least one type of cell.

2. The bioactive botanical cosmetic composition according to claim 1 , wherein said stabilizing agent is selected from the group consisting of a preservative and an antioxidant.

3. The bioactive botanical cosmetic composition according to claim 2 , wherein said preservative is selected from the group consisting of potassium sorbate, sodium benzoate, sodium methyl paraben, and citric acid.

4. The bioactive botanical cosmetic composition according to claim 2 , wherein said antioxidant is sodium metabisulfite.

5. The bioactive botanical cosmetic composition according to claim 2 , wherein said antioxidant activity is selected from the group consisting of superoxide scavenging activity and neutrophil respiratory burst inhibitory activity.

6. The bioactive botanical cosmetic composition according to claim 1 , wherein said cell serum fraction comprises between about 1 and about 10 weight percent of said bioactive botanical cosmetic composition.

7. The bioactive botanical cosmetic composition according to claim 6 , wherein said bioactive botanical cosmetic composition has a superoxide scavenging potency ranging from an ICR 50 value of between about 50 and about 190 μg of dry matter/ml, wherein said ICR 50 value represents the concentration of dry matter contained in the cell serum fraction required to inhibit 50 percent of cytochrome c reduction.

8. The bioactive botanical cosmetic composition according to claim 1 , wherein said cell serum fraction has a cell growth stimulation potency ranging from between about 1.0 and 125 μg of dry matter/ml.

9. The bioactive botanical cosmetic composition according to claim 8 , wherein said cell serum fraction has an NRU value of between about 110 and 190 percent, wherein said NRU value represents cell viability.

10. The bioactive botanical cosmetic composition according to claim 1 , wherein said bioactive botanical cosmetic composition has an ability to cause biphasic modulation of respiratory bursts from phorbol myristate acetate-stimulated neutrophils, in that said composition inhibits said respiratory bursts at between about 1.0 and 5.0 μg dry material/ml and stimulates said respiratory bursts at between about 20 and 180 μg dry material/ml.

11. A bioactive botanical cosmetic formulation, suitable for topical application to a mammal, comprising

a cosmetically acceptable carrier and

a cosmetically effective amount of the bioactive botanical cosmetic composition according to claim 1 .

12. The cosmetic formulation according to claim 11 , wherein the cosmetically acceptable carrier is selected from the group consisting of a hydrophilic cream base, a hydrophilic lotion base, a hydrophilic surfactant base, a hydrophobic cream base, a hydrophobic lotion base, and a hydrophobic surfactant base.

13. The cosmetic formulation according to claim 11 , wherein said bioactive botanical cosmetic composition is present in an amount ranging from between about 0.001 percent and about 95 percent of the total weight of the cosmetic formulation.

14. A bioactive botanical cosmetic composition comprising:

a cell serum fraction derived from cell juice extracted from a fresh plant biomass, said cell serum fraction having antioxidant activity, cell growth stimulation activity, and/or both antioxidant and cell growth stimulation activities, wherein said fresh plant biomass is plant tissue of plants selected from the group consisting of Calendula officinalis, Medicago sativa, Lavandula angustifolia, Salvia officinalis , and Hordeum vulgare ; and

a stabilizing agent, wherein said cell growth stimulation activity is due to stimulation of proliferation of at least one type of cell.

15. A method for preparing a bioactive botanical cosmetic composition, said method comprising:

providing a plant cell juice, said plant cell juice having been extracted from a fresh plant biomass, wherein said fresh plant biomass is plant tissue of plants selected from the group consisting of Asteraceae, Fabaceae, Lamiaceae, and Poaceae;

treating the plant cell juice under conditions effective to separate the plant cell juice into a membrane fraction and a cell juice supernatant;

processing the cell juice supernatant under conditions effective to separate the cell juice supernatant into a cytoplasmic fraction and a cell serum fraction;

refining the cell serum fraction under conditions effective to yield a cell serum fraction filtrate; and

stabilizing the cell serum fraction filtrate under conditions effective to yield a stable bioactive botanical cosmetic composition exhibiting said antioxidant activity, cell growth stimulation activity, or both antioxidant and cell growth stimulation activities.

16. The method according to claim 15 , wherein said fresh plant biomass is plant tissue of plants selected from the group consisting of Calendula officinalis, Medicago sativa, Lavandula angustifolia, Salvia officinalis , and Hordeum vulgare.

17. The method according to claim 15 , wherein said treating comprises:

coagulating the plant cell juice to yield a coagulated cell juice mixture, and

separating the coagulated cell juice to a membrane fraction and a cell juice supernatant.

18. The method according to claim 17 , wherein said coagulating comprises:

destabilizing the plant cell juice to yield a coagulated cell juice mixture, wherein said destabilizing is achieved by heat treatment, electro-membrane treatment, chemical treatment, and/or their combination.

19. The method according to claim 18 , wherein said heat treatment comprises:

heating the plant cell juice to a heat treatment temperature required to induce coagulation of the membrane fraction, and

cooling the heated cell juice to a temperature effective to permit quantitative separation of said membrane fraction from said cell juice supernatant.

20. The method according to claim 19 , wherein said heating is carried out at 45 to 70 degrees Celsius.

21. The method according to claim 19 , wherein said cooling is carried out at 30 to 45 degrees Celsius.

22. The method according to claim 17 , wherein said separating is carried out by filtration or centrifugation.

23. The method according to claim 15 , wherein said processing comprises:

subjecting the cell juice supernatant to a cytoplasmic fraction precipitation step to yield a cytoplasm/cell serum mixture comprising the cytoplasmic fraction and the cell serum fraction, and

separating the cytoplasmic fraction from the cell serum fraction.

24. The method according to claim 23 , wherein said cytoplasmic fraction precipitation step is carried out by isoelectric titration, electrodialysis, and/or their combination.

25. The method according to claim 24 , wherein said isoelectric titration comprises: adjusting the pH of the cell juice supernatant to between about 2.5 and 6.5.

26. The method according to claim 23 , wherein said separating is carried out by filtration or centrifugation.

27. The method according to claim 15 , wherein said refining comprises:

subjecting the cell serum fraction to a temperature treatment step to yield a coagulated cell serum fraction, and

clarifying the coagulated cell serum fraction to yield a cell serum fraction filtrate.

28. The method according to claim 27 , wherein said temperature treatment step comprises:

heating the cell serum fraction to a heating temperature required to induce coagulation within the cell serum fraction, and

cooling the cell serum fraction to a temperature effective to allow further quantitative separation of said cell serum fraction filtrate.

29. The method according to claim 28 , wherein said heating temperature is at 80 to 95 degrees Celsius.

30. The method according to claim 28 , wherein said cooling is to a temperature of at least as low as about 15 degrees Celsius.

31. The method according to claim 27 , wherein said clarifying is carried out by filtration or centrifugation.

32. The method according to claim 31 , wherein said filtration comprises:

vacuum filtrating the coagulated cell serum fraction to yield said cell serum fraction filtrate.

33. The method according to claim 15 , further comprising:

adjusting the pH of the cell serum fraction to about 3.0 to 4.0 immediately prior to said refining.

34. The method according to claim 15 , wherein said stabilizing comprises:

incubating said cell serum fraction filtrate in a mixture of at least one preservative and at least one antioxidant to yield the stable bioactive botanical cosmetic composition.

35. The method according to claim 34 , wherein said preservative is selected from the group consisting of potassium sorbate, sodium benzoate, sodium methyl paraben, and citric acid.

36. The method according to claim 34 , wherein said antioxidant is sodium metabisulfite.

37. A stable bioactive botanical cosmetic composition made by the method according to claim 15 .

38. The stable bioactive botanical cosmetic composition according to claim 37 , wherein said antioxidant activity is indicated by the ability of the bioactive botanical cosmetic composition to have a superoxide scavenging potency ranging from an ICR 50 value of between about 50 and about 190 μg dry matter/ml, wherein said ICR 50 value represents the concentration of dry matter contained in the cell serum fraction required to inhibit 50 percent of cytochrome c reduction.

39. The stable bioactive botanical cosmetic composition according to claim 37 , wherein said antioxidant activity is indicated by the ability of the bioactive botanical cosmetic composition to inhibit neutrophil respiratory burst activity.

40. The stable bioactive botanical cosmetic composition according to claim 37 , wherein said cell growth stimulation activity comprises a cell growth stimulation potency ranging from between about 1.0 and 125 μg of dry matter/ml and an NRU value of between about 110 and 190 percent, wherein said NRU value represents cell viability.

41. A stable bioactive botanical cosmetic formulation suitable for topical application to a mammal, comprising

a cosmetically acceptable carrier and

a cosmetically effective amount of the bioactive botanical cosmetic composition according to claim 37 .

42. The cosmetic formulation according to claim 41 , wherein the cosmetically acceptable carrier is selected from the group consisting of a hydrophilic cream base, a hydrophilic lotion base, a hydrophilic surfactant base, a hydrophobic cream base, a hydrophobic lotion base, and a hydrophobic surfactant base.

43. The cosmetic formulation according to claim 41 , wherein said bioactive botanical cosmetic composition is present in an amount ranging from between about 0.001 percent and about 95 percent of the total weight of the cosmetic formulation.

44. A stable bioactive botanical cosmetic composition made by the method according to claim 27 .

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2020
From: THE BANK OF NOVA SCOTIA
To: AVOCA LLC; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES LLC
Reel/Frame 051557/0504 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2015
From: AKZO NOBEL SURFACE CHEMISTRY LLC; AKZO NOBEL CHEMICALS INTERNATIONA B.V.
To: ISP INVESTMENTS INC.
Reel/Frame 036583/0320 →